KALV

KalVista Pharmaceuticals, Inc. Common Stock

15.64

USD

KALV Earnings Reports

Positive Surprise Ratio

KALV beat 24 of 36 last estimates.

67%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q4 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

KalVista Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Jan 08, 2026, KALV reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.63 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 22.62 million, with a --% difference. The market reacted with a +6.19% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were KalVista Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2026?

For Q4 2026, KalVista Pharmaceuticals, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to KalVista Pharmaceuticals, Inc. Common Stock's Q4 2026 earnings?

The stock price moved up 6.19%, changed from $15.82 before the earnings release to $16.80 the day after.

When is KalVista Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for KalVista Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on -- analysts, KalVista Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.